Publication | Closed Access

Daidzein administration in vivo reduces myocardial injury in a rat ischemia/reperfusion model by inhibiting NF-kB activation

Heart FailureCardiovascular DiseaseReperfusion InjuryMedicinePhysiologyEndothelial DysfunctionCardiovascular PharmacologyRat Ischemia/reperfusion ModelVascular BiologyPharmacotherapyNf-kb ActivationDaidzein AdministrationCardiovascular ToxicityPharmacologyOxidative Stress